Full text is available at the source.
Abstract
The evaluation assesses the cost-effectiveness of semaglutide, laparoscopic sleeve gastrectomy (LSG), and a 'do nothing' option across racial subgroups.
- Cost-effectiveness is analyzed in both Black and White groups.
- Semaglutide and LSG are compared to a control option of no intervention.
- The findings may provide insights into economic implications for different racial demographics.
Simplified